Is Bloom Energy The Best Stock to Buy Now?
Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…
Sell
40
AMBFF Quote, Financials, Valuation and Earnings
Last price:
$13.53
Seasonality move
:
-9.82%
Day range:
$13.53 - $13.53
52-week range:
$12.75 - $19.90
Dividend yield:
0.47%
P/E ratio:
40.31x
P/S ratio:
4.03x
P/B ratio:
3.80x
Volume:
--
Avg. volume:
91
1-year change:
-32.04%
Market cap:
$3.6B
Revenue:
$893.3M
EPS (TTM):
$0.34
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Ambu A/S has -- downside to fair value with a price target of -- per share.
AMBFF vs. S&P 500
-
Over the past 5 trading days, Ambu A/S has underperformed the S&P 500 by -0.1% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Ambu A/S does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Ambu A/S has grown year-over-year revenues for 11 quarters straight. In the most recent quarter Ambu A/S reported revenues of $229.5M.
Earnings Growth
-
Ambu A/S has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Ambu A/S reported earnings per share of $0.07.
Enterprise value:
3.6B
EV / Invested capital:
--
Price / LTM sales:
4.03x
EV / EBIT:
30.86x
EV / Revenue:
3.98x
PEG ratio (5yr expected):
0.24x
EV / Free cash flow:
55.67x
Price / Operating cash flow:
56.43x
Enterprise value / EBITDA:
20.86x
Gross Profit (TTM):
$530.5M
Return On Assets:
8.07%
Net Income Margin (TTM):
10%
Return On Equity:
10.21%
Return On Invested Capital:
9.33%
Operating Margin:
10.03%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $685M | $783.6M | $893.8M | $204.2M | $229.5M | |
| Gross Profit | $389M | $458.1M | $530.5M | $120.3M | $137.6M | |
| Operating Income | $43.4M | $44.6M | $115.2M | -$27.5M | $23M | |
| EBITDA | $85.5M | $146.4M | $170.4M | $35.6M | $38.2M | |
| Diluted EPS | $0.09 | $0.13 | $0.34 | -$0.07 | $0.07 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $250.6M | $303.6M | $285.1M | $394.8M | $496.9M | |
| Total Assets | $894.6M | $950.6M | $973.8M | $1.1B | $1.2B | |
| Current Liabilities | $152.7M | $153M | $133.7M | $158.5M | $182.4M | |
| Total Liabilities | $278.7M | $389.2M | $208.1M | $233.6M | $258.2M | |
| Total Equity | $616M | $561.4M | $765.7M | $837.5M | $950M | |
| Total Debt | $128.3M | $243.1M | $82.9M | $83.5M | $86.1M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $76.3M | $118.1M | $124.1M | $28.4M | $41.4M | |
| Cash From Investing | -$46.8M | -$42.1M | -$60.3M | -$14M | -$19.8M | |
| Cash From Financing | -$33.5M | -$9.5M | -$24.1M | -$2.7M | -$3M | |
| Free Cash Flow | $29.5M | $76.1M | $63.9M | $14.4M | $21.6M | |
AMBFF
Sector
Market Cap
$3.6B
$27.9M
Price % of 52-Week High
67.97%
51.04%
Dividend Yield
0.47%
0%
Shareholder Yield
0.32%
-1.49%
1-Year Price Total Return
-32.04%
-16.66%
Beta (5-Year)
0.809
0.516
Dividend yield:
0.47%
Annualized payout:
$0.05
Payout ratio:
95.1%
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$13.33
200-day SMA
Sell
Level
$15.87
Bollinger Bands (100)
Sell
Level
13.63 - 15.67
Chaikin Money Flow
Buy
Level
29.9K
20-day SMA
Buy
Level
$13.03
Relative Strength Index (RSI14)
Buy
Level
58.02
ADX Line
Buy
Level
62.84
Williams %R
Sell
Level
0
50-day SMA
Sell
Level
$14.02
MACD (12, 26)
Sell
Level
-0.09
25-day Aroon Oscillator
Buy
Level
40
On Balance Volume
Neutral
Level
21.7K
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (11.9233)
Buy
CA Score
(Annual)
Level (1.6066)
Buy
Beneish M-Score
(Annual)
Level (-2.4616)
Buy
Momentum Score
Level (3)
Buy
Ohlson Score
Level (-3.1821)
Buy
Piotroski F Score
(Annual)
Level (9)
Buy
Quality Ratio Score
Level (8)
Buy
Fundamental Score
Level (8)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Ambu A/S engages in the development, production, and marketing of diagnostic and life-supporting devices for hospitals and rescue services. It operates through the following segments: Anaesthesia; Patient Monitoring & Diagnostics; and Visualisation. The Anaesthesia segment offers products from resuscitators, face masks, and laryngeal masks to the single use flexible intubation scope. The Patient Monitoring & Diagnostics segmet provides electrodes for cardiology, neurophysiology, and polysomnography. The Visualisation segment includes single-use visualisation devices, which are used in single lung ventilation procedure, or a bedside bronchoscopy procedure in the intensive care unit . The company was founded by Holger Hesse in 1937 and is headquartered in Ballerup, Denmark.
Stock Forecast FAQ
In the current month, AMBFF has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The AMBFF average analyst price target in the past 3 months is --.
-
Where Will Ambu A/S Stock Be In 1 Year?
According to analysts, the consensus estimate is that Ambu A/S share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Ambu A/S?
Analysts are divided on their view about Ambu A/S share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Ambu A/S is a Sell and believe this share price will rise from its current level to --.
-
What Is Ambu A/S's Price Target?
The price target for Ambu A/S over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is AMBFF A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Ambu A/S is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of AMBFF?
You can purchase shares of Ambu A/S via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Ambu A/S shares.
-
What Is The Ambu A/S Share Price Today?
Ambu A/S was last trading at $13.53 per share. This represents the most recent stock quote for Ambu A/S. Yesterday, Ambu A/S closed at $13.53 per share.
-
How To Buy Ambu A/S Stock Online?
In order to purchase Ambu A/S stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get AMBFF Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
AMBFF
Sector
P/E ratio
40.31x
23.85x
PEG ratio
0.24x
-0.01x
P/B ratio
3.80x
1.81x
Price / LTM sales
4.03x
1.58x
Growth Metrics
AMBFF
Sector
Revenue growth
12.39%
4.62%
Earnings growth
190.48%
10.5%
Revenue (5-year growth)
10.79%
6.5%
Earnings forecast
--
-$0.21
Profitability
AMBFF
Sector
Profitability FY 2025
$500M
$3.6M
Return on invested capital
9.33%
-31.87%
Return on assets
8.07%
-28.18%
Return on equity
10.21%
-37.63%
Earnings Date
Last Earnings Date
Nov
5
Next Earnings Date
Feb
4
Estimated Next Earnings Date
Feb
4
Balance Sheet
AMBFF
Sector
Total cash
$136.3M
$26.4M
Short term investments
--
$25.7M
Total assets
$1.2B
$76.9M
Long term debt
$86.1M
$3.4M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Berkshire Hathaway Stock Undervalued?
Berkshire Hathaway (NYSE:BRK.A,BRK.B) has undershot the market this year, returning…
Is Oracle Stock Undervalued?
Shares of Oracle (NYSE:ORCL) rocketed higher earlier this year when…
Stock Ideas
Buy
54
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
57
Is GOOG Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 38x
Alerts
Sell
1
LW alert for Dec 20
Lamb Weston Holdings, Inc. [LW] is down 25.96% over the past day.
Buy
54
BMRN alert for Dec 20
BioMarin Pharmaceutical, Inc. [BMRN] is up 17.79% over the past day.
Buy
82
RKLB alert for Dec 20
Rocket Lab Corp. [RKLB] is up 17.72% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
